These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24127777)

  • 21. New insights into the interactions between dendrimers and surfactants: 2. Design of new drug formulations based on dendrimer-surfactant aggregates.
    Cheng Y; Wu Q; Li Y; Hu J; Xu T
    J Phys Chem B; 2009 Jun; 113(24):8339-46. PubMed ID: 19469491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendrimers as size selective inhibitors to protein-protein binding.
    Chiba F; Hu TC; Twyman LJ; Wagstaff M
    Chem Commun (Camb); 2008 Sep; (36):4351-3. PubMed ID: 18802567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting protein-protein interactions and fragment-based drug discovery.
    Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
    Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoromic acid derivatives: a new family of small-molecule pre-mRNA splicing inhibitors discovered by a stage-specific high-throughput in vitro splicing assay.
    Samatov TR; Wolf A; Odenwälder P; Bessonov S; Deraeve C; Bon RS; Waldmann H; Lührmann R
    Chembiochem; 2012 Mar; 13(5):640-4. PubMed ID: 22334518
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Protein Degradation: from Chemical Biology to Drug Discovery.
    Cromm PM; Crews CM
    Cell Chem Biol; 2017 Sep; 24(9):1181-1190. PubMed ID: 28648379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
    Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L
    Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers.
    Lawson ADG; MacCoss M; Heer JP
    J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendrimers as artificial enzymes.
    Kofoed J; Reymond JL
    Curr Opin Chem Biol; 2005 Dec; 9(6):656-64. PubMed ID: 16260174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linkers for protein degradation.
    P Chamberlain P
    Nat Chem Biol; 2018 Jul; 14(7):639-640. PubMed ID: 29892082
    [No Abstract]   [Full Text] [Related]  

  • 31. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of small molecule sphingomyelin synthase inhibitors.
    Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
    Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dendrimers on pure acetylcholinesterase activity and structure.
    Shcharbin D; Jokiel M; Klajnert B; Bryszewska M
    Bioelectrochemistry; 2006 Jan; 68(1):56-9. PubMed ID: 15923153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-binding small molecules as inhibitors of transcription factors.
    Leung CH; Chan DS; Ma VP; Ma DL
    Med Res Rev; 2013 Jul; 33(4):823-46. PubMed ID: 22549740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 1).
    Wilson AJ; Gunning PT
    Chembiochem; 2016 Apr; 17(8):644-5. PubMed ID: 27027879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocket.
    Lopez-Garcia LA; Schulze JO; Fröhner W; Zhang H; Süss E; Weber N; Navratil J; Amon S; Hindie V; Zeuzem S; Jørgensen TJ; Alzari PM; Neimanis S; Engel M; Biondi RM
    Chem Biol; 2011 Nov; 18(11):1463-73. PubMed ID: 22118680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoinformatics and library design.
    Zhou JZ
    Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.
    van Linden OP; Farenc C; Zoutman WH; Hameetman L; Wijtmans M; Leurs R; Tensen CP; Siegal G; de Esch IJ
    Eur J Med Chem; 2012 Jan; 47(1):493-500. PubMed ID: 22137457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.